# Arbutus Biopharma Corp: Form 8-K, filed Mar 7, 2019

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2019-03-07
- Accepted by EDGAR: Mar 7, 2019, 16:29 ET
- Period: 2019-03-07
- Accession: 0001171843-19-001586
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184319001586/f8k_030719.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184319001586/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184319001586/f8k_030719.htm

Filed Mar 7, 2019.
Source: SEC EDGAR, the filing index for accession 0001171843-19-001586. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.